Published in Nat Commun on February 16, 2017
AKT1, LKB1, and YAP1 revealed as MYC interactors with NanoLuc-based protein-fragment complementation assay. Mol Pharmacol (2017) 0.75
Targeting MYC Dependence by Metabolic Inhibitors in Cancer. Genes (Basel) (2017) 0.75
OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (2010) 26.76
Cancer genome landscapes. Science (2013) 25.33
Towards a proteome-scale map of the human protein-protein interaction network. Nature (2005) 24.76
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54
Mutational landscape and significance across 12 major cancer types. Nature (2013) 14.91
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature (2010) 14.62
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
Signaling--2000 and beyond. Cell (2000) 11.78
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Discovery and saturation analysis of cancer genes across 21 tumour types. Nature (2014) 11.68
Comprehensive molecular profiling of lung adenocarcinoma. Nature (2014) 11.02
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res (2010) 10.97
STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res (2014) 10.79
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature (2007) 9.12
Mutual exclusivity analysis identifies oncogenic network modules. Genome Res (2011) 7.22
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res (2002) 7.09
14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol (2000) 6.94
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer. N Engl J Med (2015) 6.38
Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09
The Pfam protein families database: towards a more sustainable future. Nucleic Acids Res (2015) 5.97
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci U S A (2004) 5.16
LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell (2013) 4.58
The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res (2013) 4.39
The BioGRID interaction database: 2015 update. Nucleic Acids Res (2014) 4.06
A proteome-scale map of the human interactome network. Cell (2014) 3.91
Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell (2010) 3.40
Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene (2003) 2.57
The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell (2015) 2.41
NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines. Genomics (2001) 1.85
Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J (2010) 1.73
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities. Cancer Discov (2015) 1.64
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors. Cancer Cell (2016) 1.61
An overview of MYC and its interactome. Cold Spring Harb Perspect Med (2014) 1.53
2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition. Mol Cancer Ther (2008) 1.29
Targeting protein-protein interactions as an anticancer strategy. Trends Pharmacol Sci (2013) 1.29
NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov (2014) 1.27
Charting the landscape of tandem BRCT domain-mediated protein interactions. Sci Signal (2012) 1.19
A rationale to target the SWI/SNF complex for cancer therapy. Trends Genet (2014) 1.17
3did: a catalog of domain-based interactions of known three-dimensional structure. Nucleic Acids Res (2013) 1.14
The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J Biol Chem (2000) 1.14
Pathogenesis of lung cancer signalling pathways: roadmap for therapies. Eur Respir J (2009) 1.10
CDK4: A Key Player in the Cell Cycle, Development, and Cancer. Genes Cancer (2012) 1.07
Negatome 2.0: a database of non-interacting proteins derived by literature mining, manual annotation and protein structure analysis. Nucleic Acids Res (2013) 1.01
NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. Mol Cell (2015) 0.98
Using functional signature ontology (FUSION) to identify mechanisms of action for natural products. Sci Signal (2013) 0.94
Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Mol Cell Biol (1996) 0.85
Hippo and rassf1a Pathways: A Growing Affair. Mol Biol Int (2012) 0.83
Integration of apoptosis signal-regulating kinase 1-mediated stress signaling with the Akt/protein kinase B-IκB kinase cascade. Mol Cell Biol (2013) 0.82
A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition. Cancer Res (2013) 0.81
LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion. Mol Biol Cell (2016) 0.81
Uncovering disease mechanisms through network biology in the era of Next Generation Sequencing. Sci Rep (2016) 0.80
Regulation of c-Myc protein stability by proteasome activator REGγ. Cell Death Differ (2014) 0.80
[Effect of acitretin and methotrexate on treatment of severe plaque psoriasis]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2016) 0.75
AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex. J Mol Cell Biol (2016) 0.75
[Association between C reactive protein and clinical characteristics in patients with chronic spontaneous urticaria]. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2017) 0.75
[Amplification of beta-catenin gene in the paraffin-embedded epidermal tissue]. Hunan Yi Ke Da Xue Xue Bao (2003) 0.75